Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page; a minor backend update with no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedNew study locations have been added across multiple US states and international sites (Argentina, Brazil, Mexico) and previous location entries have been removed; this update is labeled Revision: v3.3.3.SummaryDifference2%

- Check56 days agoChange DetectedPublication section wording updated to clarify that PubMed entries are automatically populated and may not all relate to the study, and a Revision: v3.3.2 tag was added.SummaryDifference0.1%

- Check63 days agoChange DetectedThe administrative notice about government funding and operating status was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check77 days agoChange DetectedNo significant changes detected in study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check106 days agoChange Detected- Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).SummaryDifference4%

Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.